Brief: China Resources Pharmaceutical Group Ltd Says Fy Revenue For Dong-E-E-Jiao Rmb4.041 Bln
March 27 (Reuters) - China Resources Pharmaceutical
Group Ltd 3320.HK :
* FY REVENUE FOR DONG-E-E-JIAO RMB4.041 BILLION VERSUS
RMB3.85
BILLION
* FY NET PROFIT ATTRIBUTABLE RMB780 MILLION VERSUS RMB440.4
MILLION FOR DONG-E-E-JIAO CO., LTD.
Further company coverage: 3320.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Says KPC Pharmaceuticals Reports Nine Month Results
Brief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals